Kemoplat Injection (Cisplatin) | Platinol | Anticancer Medicine | Used to Treat Ovarian, Cervical, and Testicular Cancer
Kemoplat Injection (Cisplatin) Kemoplat Injection is used to treat various cancers such as lung, ovarian, bladder, cervical, and testicular cancer. The measurements depend on your ailment, body size, and reaction to treatment. During treatment with this drug, you should take in more liquids than expected and urinate every now and again to assist with keeping away from kidney secondary effects. Platinol is another trade name for Cisplatin.
Product Overview
Kemoplat Injection contains Cisplatin, a chemotherapy agent widely used in oncology to treat a broad range of malignant tumors. As a cytotoxic medication, it functions by interfering with the DNA replication process of rapidly dividing cells, effectively inhibiting tumor growth and inducing cell death. Due to its potent nature and specific side-effect profile—which requires careful management of renal, auditory, and gastrointestinal health—Kemoplat is administered exclusively under the expert supervision of an oncologist in a clinical setting equipped to handle cytotoxic therapies. Its targeted mechanism makes it a foundational component of various multi-drug chemotherapy regimens designed to manage solid organ malignancies.
Product Composition
- Active Ingredient: Cisplatin (commonly available in concentrations such as 1 mg/mL).
- Excipients: Sodium chloride (for isotonicity) and hydrochloric acid or sodium hydroxide (for pH adjustment).
Product Specification
| Feature | Details |
| Brand Name | Kemoplat Injection |
| Active Ingredient | Cisplatin |
| Therapeutic Category | Platinum-based antineoplastic agent |
| Form | Concentrated solution for injection/infusion |
| Primary Indications | Testicular, ovarian, bladder, lung, and head & neck cancers |
| Storage Requirements | Room temperature (do not refrigerate), protect from light |
Mechanism of Action
- DNA Binding: Cisplatin enters the cancer cell and undergoes activation; it then binds directly to DNA, creating "cross-links" between and within DNA strands.
- Inhibition of Replication: These cross-links create structural distortions in the DNA molecule, which prevents the cell from accurately replicating its genetic material.
- Apoptosis Induction: The damage to the DNA is recognized by the cell’s repair mechanisms; when the damage is too severe to fix, the cell initiates programmed cell death, known as apoptosis.
Key Benefits & Indications
- Solid Tumor Management: Highly effective as a backbone therapy for metastatic or localized solid tumors, particularly in testicular and ovarian cancers.
- Synergistic Efficacy: Often used in combination with other chemotherapeutic agents and radiation therapy to enhance the overall anti-tumor response in lung and head/neck cancers.
- Adjuvant Therapy: Frequently utilized following surgical resection to eliminate residual malignant cells and reduce the risk of recurrence.
Precautions
Hospital Use Only
- Kemoplat Injection (Cisplatin) must be administered only in a hospital or oncology center by trained healthcare professionals
- Not for self-administration
Kidney Function Monitoring
- Cisplatin can affect kidney function
- Regular kidney function tests and adequate hydration are essential before and after treatment
Blood Count Monitoring
- May lower white blood cells, red blood cells, and platelets
- Frequent blood tests are required during therapy
Hydration Requirement
- Adequate intravenous fluids are usually given before and after infusion
- Helps reduce kidney toxicity
Hearing and Nerve Effects
- May cause hearing problems (tinnitus or hearing loss)
- Can also cause nerve damage such as tingling or numbness in hands and feet
Pregnancy and Breastfeeding
- Not recommended during pregnancy or breastfeeding
- Strict contraception is required during treatment
| Precaution Area | Guidance |
|---|---|
| Administration | Hospital use only |
| Kidney Health | Regular monitoring required |
| Blood Counts | Frequent testing needed |
| Hydration | Adequate fluids essential |
| Hearing/Nerves | Monitor for toxicity signs |
| Pregnancy | Strictly avoid during treatment |
Usage
Dosage & Administration
Clinical Setting Only: Kemoplat must be administered exclusively by trained oncology professionals in a clinical environment capable of managing cytotoxic agents and potential infusion reactions.
Intravenous Infusion: The medication is administered via slow intravenous (IV) infusion. The dosage is meticulously calculated by the oncologist based on the patient’s body surface area, renal function, and specific treatment protocol.
Hydration Protocol: Strict adherence to pre-treatment and post-treatment intravenous hydration is mandatory. This is critical to maintain urine output and protect the kidneys from the drug's potential toxic effects.
Anti-Emetic Support: To manage the high risk of nausea and vomiting, patients are typically administered a potent regimen of anti-nausea medications before and after the infusion.
Safety Precautions
Renal Monitoring: Kidney function (serum creatinine, blood urea nitrogen) must be closely monitored before every dose. If renal impairment occurs, the treatment schedule or dosage may be adjusted.
Ototoxicity Screening: Patients should report any hearing loss or tinnitus (ringing in the ears) immediately. Regular audiometric testing is recommended for patients receiving multiple cycles of therapy.
Neurological Monitoring: Be vigilant for signs of peripheral neuropathy, such as numbness, tingling, or weakness in the extremities. Notify your healthcare team promptly if these occur.
Handling & Storage: The product must be stored at controlled room temperature, protected from light. It must not be refrigerated, as this can cause the medication to precipitate.
Treatment Administration Summary
| Protocol | Requirement |
| Frequency | Determined by the specific oncology treatment cycle (e.g., every 3–4 weeks) |
| Intake Method | Intravenous (IV) infusion with mandatory hydration |
| Monitoring | Frequent blood counts, renal function tests, and audiometry |
| Key Warning | Requires aggressive pre-medication for nausea and high hydration volumes |
Uses
Metastatic Testicular Cancer: A primary treatment component, often leading to high cure rates in combination with other chemotherapy agents.
Ovarian & Bladder Cancer: Utilized to manage advanced or recurrent disease, often used in combination protocols.
Advanced Non-Small Cell Lung Cancer (NSCLC): A standard therapeutic option used to slow tumor progression and improve survival in combination regimens.
Head & Neck Squamous Cell Carcinomas: Administered to shrink tumors prior to surgery or in combination with radiation therapy to enhance treatment outcomes.
Side Effects
Common Side Effects
- Nausea and vomiting
- Loss of appetite
- Fatigue or weakness
- Hair loss (temporary)
Kidney Related Effects
- Reduced kidney function
- Increased creatinine levels
- Decreased urine output in severe cases
Blood Related Effects
- Low white blood cells (increased infection risk)
- Low platelets (easy bruising or bleeding)
- Anemia (tiredness, dizziness)
Nervous System Effects
- Numbness or tingling in hands and feet (peripheral neuropathy)
- Hearing problems such as ringing in ears (tinnitus) or hearing loss
Gastrointestinal Effects
- Severe nausea and vomiting
- Diarrhea or stomach discomfort
Serious but Rare Effects
- Severe allergic reactions
- Electrolyte imbalance (low magnesium, potassium)
- Kidney failure in severe cases
| Side Effect Type | Details |
|---|---|
| Common Effects | Nausea, fatigue, hair loss |
| Kidney Effects | Reduced function, toxicity |
| Blood Effects | Low WBC, anemia, low platelets |
| Nervous System | Tingling, hearing loss |
| GI Effects | Vomiting, diarrhea |
| Serious Effects | Kidney failure, severe allergy, electrolyte imbalance |
FAQs
Q: What is Kemoplat (Cisplatin) used for?
A: Kemoplat is a chemotherapy medication used to treat various types of cancer, including testicular, ovarian, bladder, lung, and head and neck cancers. It is often used as part of a combination therapy.
Q: How is this medication administered?
A: It is administered by an oncologist or trained nurse through an intravenous (IV) infusion in a hospital or clinical setting.
Q: Why is hydration so important during treatment?
A: Cisplatin can be toxic to the kidneys (nephrotoxic). Patients receive intravenous fluids before and after the infusion to ensure the kidneys remain hydrated, which helps flush the drug out of the body and minimizes kidney damage.
Q: Can I experience nausea and vomiting?
A: Yes, Cisplatin is considered "highly emetogenic," meaning it causes significant nausea and vomiting. You will be prescribed strong anti-nausea medications (anti-emetics) to take before and during your treatment to manage these side effects.
Q: What is "ototoxicity," and why is it mentioned?
A: Ototoxicity refers to hearing damage. Cisplatin can cause hearing loss or ringing in the ears (tinnitus). You may undergo baseline and periodic hearing tests (audiograms) to monitor for any changes.
Q: How does this medication affect my blood counts?
A: Like many chemotherapy drugs, Cisplatin can suppress bone marrow, leading to lower levels of white blood cells (increasing infection risk), red blood cells (anemia), and platelets (bleeding risk). Regular blood tests are necessary to monitor these counts.
Q: Is it safe for pregnant women?
A: No. Cisplatin can harm the fetus and is strictly contraindicated during pregnancy. Women of childbearing potential must use effective contraception during treatment.
Q: What should I do if I experience numbness or tingling?
A: Some patients experience peripheral neuropathy—a sensation of numbness, tingling, or "pins and needles" in the hands or feet. Inform your oncology team immediately if you notice these symptoms.
Q: Can I drive after receiving an infusion?
A: Because of the potential for nausea, fatigue, and other side effects from both the medication and the pre-medications, it is recommended that you arrange for someone else to drive you home after your treatment sessions.
Q: How is Kemoplat stored?
A: It must be stored at room temperature and protected from light. It should not be refrigerated, as this can cause the medication to precipitate (form crystals).
Interactions
Other Chemotherapy Medicines
- Kemoplat Injection (Cisplatin) is often used with other anticancer drugs
- Combination therapy must be carefully managed by an oncologist to avoid increased toxicity
Kidney-Affecting Drugs
- Medicines that affect kidney function (e.g., certain antibiotics or diuretics) may increase risk of kidney damage
- Close monitoring or dose adjustment is required
Aminoglycoside Antibiotics
- Drugs like gentamicin or amikacin may increase kidney and ear toxicity
- Should be avoided or used only under strict supervision
Diuretics (Water Pills)
- Loop diuretics such as furosemide may increase risk of hearing and kidney damage
- Use only with careful medical monitoring
Vaccines and Immune System Drugs
- Live vaccines should be avoided during chemotherapy
- Immunosuppressants may increase infection risk
| Interaction Type | Recommendation |
|---|---|
| Other Chemotherapy Drugs | Use only under oncologist supervision |
| Kidney-Affecting Medicines | Increased toxicity risk |
| Aminoglycoside Antibiotics | Avoid if possible |
| Diuretics | Use with caution and monitoring |
| Vaccines | Avoid live vaccines during treatment |
| Manufacturer | : | Fresenius Kabi, India |
| Trade Name | : | Platinol |
| Generic Search | : | Cisplatin |
| Strength | : | 10mg, 50 mg |
Latest Products
